The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system.
Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken. The product is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder and for use as an add-on treatment for depression in adults.
The system works by sending a message from the pill’s sensor to a wearable patch. The patch transmits the information to a mobile application so that patients can track the ingestion of the medication on their smart phone. Patients can also permit their caregivers and physician to access the information through a web-based portal.
“Being able to track ingestion of medications prescribed for mental illness may be useful for some patients,” said Mitchell Mathis, M.D., director of the Division of Psychiatry Products in the FDA’s Center for Drug Evaluation and Research. “The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers.”
It is important to note that Abilify MyCite’s prescribing information (labeling) notes that the ability of the product to improve patient compliance with their treatment regimen has not been shown. Abilify MyCite should not be used to track drug ingestion in “real-time” or during an emergency because detection may be delayed or may not occur.
Schizophrenia is a chronic, severe and disabling brain disorder. About 1 percent of Americans have this illness. Typically, symptoms are first seen in adults younger than 30 years of age. Symptoms of those with schizophrenia include hearing voices, believing other people are reading their minds or controlling their thoughts, and being suspicious or withdrawn. Bipolar disorder, also known as manic-depressive illness, is another brain disorder that causes unusual shifts in mood, energy, activity levels and the ability to carry out day-to-day tasks. The symptoms of bipolar disorder include alternating periods of depression and high or irritable mood, increased activity and restlessness, racing thoughts, talking fast, impulsive behavior and a decreased need for sleep.
Abilify MyCite contains a Boxed Warning alerting health care professionals that elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Abilify MyCite is not approved to treat patients with dementia-related psychosis. The Boxed Warning also warns about an increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants. The safety and effectiveness of Abilify MyCite have not been established in pediatric patients. Patients should be monitored for worsening and emergence of suicidal thoughts and behaviors. Abilify MyCite must be dispensed with a patient Medication Guide that describes important information about the drug’s uses and risks.
In the clinical trials for Abilify, the most common side effects reported by adults taking Abilify were nausea, vomiting, constipation, headache, dizziness, uncontrollable limb and body movements (akathisia), anxiety, insomnia, and restlessness. Skin irritation at the site of the MyCite patch placement may occur in some patients.
Prior to initial patient use of the product, the patient’s health care professional should facilitate use of the drug, patch and app to ensure the patient is capable and willing to use the system.
Abilify was first approved by the FDA in 2002 to treat schizophrenia. The ingestible sensor used in Abilify MyCite was first permitted for marketing by the FDA in 2012.
The Latest on: Digital ingestion tracking system
- Informatica Expands Data Governance Support For The Snowflake Data Cloudon November 19, 2020 at 5:29 pm
Informatica is stepping up its strategic alliance with cloud data platform company Snowflake, offering new data cataloging and governance capabilities that businesses and organizations can use to ...
- How Snowflake plans to change a flawed data warehouse modelon November 14, 2020 at 2:14 pm
Snowflake Inc. will not grow into its heady valuation by simply stealing share from the on-premises data warehouse providers. Even if it got 100% of the data warehouse business, it wouldn’t come close ...
- FDA Approves First Digital Pill That Can Track Whether You've Taken Iton November 14, 2020 at 8:37 am
The Food and Drug Administration has approved its first digital drug ... "Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," said Dr ...
- ABILIFY MYCITE, The First FDA Approved Digital Medicine That Tracks Its Own Ingestionon November 13, 2020 at 4:01 pm
Proteus Digital Health, a Redwood City firm ... Because such patients often tend to skip their meds, the new tracking system may help to ensure they stay on track, resulting in optimal therapy ...
- FDA Approves World's First Pill with an Embedded Sensoron November 10, 2020 at 4:00 pm
Patient compliance has always been an issue in healthcare and one that digital health technologies such as wearables ... manufactured by Japan-based Otsuka Pharmaceutical. “Being able to track ...
- Synechron launches accelerator programme for investment management industryon November 3, 2020 at 5:03 am
Synechron, Inc., a leading Digital Transformation Consulting firm ... as well as automating processes for buy-side firms that include tracking regulatory compliance requirements.
- Amazon Web Services helps Navy transform its digital capabilitieson October 28, 2020 at 9:05 pm
Damon Harding, Digital Group Cloud Lead at Naval Air Systems Command Headquarters ... and data scientists with a method for continuous data ingestion as well as the ability to search, access ...
- Ingestible Sensor Serves as Prescription Drug Monitoron October 19, 2020 at 5:00 pm
Pharmaceutical makers can begin using the Ingestion Event Marker (IEM) from Proteus Digital Health as part of a system that helps people monitor ... In addition to tracking when someone took a pill, ...
- Gov't Approves First-Ever Med With Digital Tracking Systemon November 14, 2017 at 9:27 am
The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system. 412 Food Rescue Virtual ConcertWiz Khalifa, Andrew McCutchen and other ...
via Google News and Bing News